Nanosonics logo

NAN - Nanosonics Share Price

A$5.8 -0.4  -6.0%

Last Trade - 6:10am

Sector
Healthcare
Size
Mid Cap
Market Cap £909.3m
Enterprise Value £870.2m
Revenue £45.2m
Position in Universe 158th / 1835
Bullish
Bearish
Unlock NAN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NAN Revenue Unlock NAN Revenue

Net Income

NAN Net Income Unlock NAN Revenue

Normalised EPS

NAN Normalised EPS Unlock NAN Revenue

PE Ratio Range

NAN PE Ratio Range Unlock NAN Revenue

Dividend Yield Range

NAN Dividend Yield Range Unlock NAN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NAN EPS Forecasts Unlock NAN Revenue
Profile Summary

Nanosonics Ltd is an Australia-based company focused on developing automated disinfection technology. The Company’s principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories and research, development and commercialization of infection control and decontamination products and related technologies. The Company’s automated Trophon electron paramagnetic resonance (EPR) disinfection device provides solutions for care in ultrasound probe disinfection practices. trophon is its solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs). Its trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Its consumable and accessories include NanoNebulant, trophon Chemical Indicator, trophon AcuTrace Operator Card and trophon Printer.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated November 14, 2000
Public Since May 17, 2007
No. of Shareholders: 13,113
No. of Employees: 286
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries , S&P/ASX 200 , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 300,476,051
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NAN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NAN
Upcoming Events for NAN
Similar to NAN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.